Health

NCDC Issues Public Health Advisory On Human Metapneumovirus (HMPV)

There is no specific antiviral treatment or vaccine for HMPV.

Published

5 months ago

January 7, 2025

OCHEFA

The Nigeria Centre for Disease Control and Prevention (NCDC) has issued the following Public Health Advisory on Human Metapneumovirus (HMPV) Awareness, Preparedness, and Prevention.

The document released by, Dr. Jide Idris, the Director – GeneralNigeria Centre for Disease Control and Prevention, said :

” NCDC is committed to safeguarding the health of all Nigerians. In response to recent reports of increased Human Metapneumovirus (HMPV) activity in China and other affected regions, as well as growing public interest in the matter, the NCDC in collaboration with the Federal Ministry of Health and Social Welfare is closely monitoring global developments.

We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared. Global situation update.

It is important to note that the rumor circulating about the World Health Organization (WHO) declaring HMPV a Public Health Emergency of International Concern (PHEIC) is false and should be disregarded.

The WHO has not made such a declaration. Recent reports indicate a significant rise in Human Metapneumovirus (HMPV) cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.

The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.

This trend emphasizes the need for heightened preparedness and vigilance.

Current Situation in Nigeria

Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.

These sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).

As of January 6, 2025, data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by Human Metapneumovirus (HMPV).

However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.

NCDC Preparedness Measures

The NCDC is closely monitoring the situation and has implemented the following actions to ensure public health safety:

1. Dynamic Risk Assessment

On January 6, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).

The assessment classified the risk of HMPV for Nigeria as moderate.

This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.

2. Public Health Advisory:

Issued this advisory to provide Nigerians with up-to-date information on preparedness actions and preventive measures.

3. Point of Entry (POE):

The Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).

These measures are designed to mitigate the potential risk of HMPV transmission through international travel. Key actions include

▪︎ Conducting a comprehensive situation analysis at all international PoEs to assess current readiness levels.

▪︎ An Entry Implementation Protocol on HMPV, approved by the Honourable Minister of Health and Social Welfare, is being developed and will be distributed to all points of entry to guide response activities.

▪︎ In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required.

▪︎ Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols.

▪︎ Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.

4. Enhanced Surveillance and Laboratory Diagnosis:

The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).

This platform, which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted.

Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.

5. Infection Prevention and Control (IPC):

Advisories have been issued to hospitals nationwide on enhanced IPC practices, including proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette.

All health facilities are required to identify an appropriate isolation room where cases can be quickly isolated while receiving care.

6. Case Management Preparedness:

Collaborating with state governments and healthcare facilities to provide training for healthcare workers to ensure adequate case management teams are in place and ready to respond if needed.

This will ensure that healthcare workers are able to provide appropriate care and maintain a high index of suspicion. Supportive care and an emphasis on a high index of suspicion are crucial.

We are requesting state governments to activate their treatment centers or isolation centers to ensure they are prepared to manage cases appropriately.

7. Stockpiling of Medical Countermeasures:

Relevant materials such as PPEs (face masks, hand gloves, hand hygiene supplies, and other essential IPC items) have been stockpiled for rapid deployment if required.

Additionally, laboratory consumables, reagents, and other necessary supplies have also been stockpiled to ensure readiness.

Risk Communication and Community Engagement:Engaging with the public through clear and accurate messages to address concerns, dispel misinformation, and encourage appropriate health-seeking behaviors.

We work in close collaboration with state risk communication and community engagement pillars, health educators, and other trusted voices, such as the media.

These efforts reflect NCDC’s commitment to proactive coordination and response at all levels of public health.

Public Advisory What is HMPV?

Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in:

• Young children •

Older adults

• Individuals with weakened immune systems

There is no specific antiviral treatment or vaccine for HMPV.

Supportive care, such as rest, hydration, and fever management, remains the primary approach to recovery.

Symptoms

• Cough

• Fever

• Nasal congestion

• Shortness of breath

• Wheezing

• Bronchitis or pneumonia (in vulnerable populations such as very young children, older people, patients with low immunity such and those on cancer treatment, uncontrolled diabetes etc).

The incubation period is 3-5 days after exposure, and infections typically resolve within 2-5 days with supportive care.

We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.

However, high-risk populations may experience complications.

Transmission HMPV spreads through:

• Respiratory droplets from coughing and sneezing

• Close personal contact (e.g., touching or shaking hands)

• Touching contaminated surfaces and then touching the face.

Overcrowding and poor ventilation can lead to increased transmission, e.g., in congregate settings such as correctional centers and poorly managed IDPs.

Preventive Measures

To reduce the risk of HMPV infection, the public is advised to follow these preventive steps:

For the General Public:

• Hand Hygiene: Wash hands frequently with soap and water for at least 20 seconds.

• Respiratory Etiquette: Cover your mouth and nose with a tissue or elbow when coughing or sneezing. Cover your mouth an nose with face mask if you are experiencing flu like symptoms.

• Avoid Close Contact: Maintain distance from individuals showing symptoms of respiratory illness.

• Avoid overcrowded places.

• Disinfect Surfaces: Regularly clean and disinfect frequently touched objects and surfaces.

• Self-Isolation: Stay home if experiencing symptoms to prevent spreading the virus. As is correct parctice and seek medical care from appropriate sources.

Protecting Vulnerable Groups:

• Young children, older adults, and individuals with underlying health conditions such as people with chronic diseases such as diabetes, on cancer treatment, immunicompromised paients or those with low immunity should seek prompt medical attention if experiencing severe symptoms. Healthcare Guidance

For Healthcare Workers:

• Reinforce Infection Prevention and Control (IPC) measures in healthcare facilities.

• Enhance surveillance for acute respiratory infections and report unusual increases to the relevant authorities. Index of suspiciona nd enhanced

• Use appropriate PPE when attending to patients with respiratory symptoms.

• Educate patients on preventive measures and when to seek emergency medical care.

• Provide symptomatic care and promptly refer severe cases to specialist facilities.

Conclusion

The NCDC remains dedicated to protecting the health of Nigerians through continuous surveillance and prompt response to infectious diseases.

We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.

We also emphasize the importance of relying on verified information from the NCDC and WHO.

For emergencies, please contact the NCDC’s toll-free line at 6232 or email us at info@ncdc.gov.ng.

Together, we can protect our communities from respiratory infections and ensure a healthier Nigeria.

Contact Information • Toll-Free Number: 6232 • SMS: *** • WhatsApp: *** • Twitter: @NCDCGov • Facebook: @NCDCgov • Instagram: @NCDCgov

Related Topics:Featured HMPV public advisory Human Metapneumovirus

Up Next

Lagos To Begin Response Against Wild Polio Virus Outbreaks

Don't Miss

NCDC Alerts Against China’s New HMPV

Click to comment

Health

Aliko Dangote Foundation Donates Ambulance to Mainland Hospital Yaba

The donated ambulance is expected to greatly improve the hospital’s emergency response capabilities, enabling swift mobility for critical cases and enhancing overall efficiency in disease outbreak responses.

Published

1 month ago

April 28, 2025

OhiBaba

the Aliko Dangote Foundation (ADF) has donated a brand-new ambulance to Mainland Hospital in Yaba, Lagos.

The hospital’s MD/CEO, Dr. Adejumo Adedeji Olusola, said that the donation has addressed a longstanding challenge, allowing the hospital to perform tasks that were previously impossible.

“We are really grateful, and our sincere gratitude goes to Mr. Aliko Dangote. We lacked an ambulance for about 10 years, but now we have one we can boast of thanks to Mr. Aliko Dangote,” Dr. Olusola said.

The Aliko Dangote Foundation has been at the forefront of major health interventions in Nigeria, including efforts to combat malnutrition, polio, and pandemic outbreaks.

This donation reflects the foundation’s broader mission to strengthen Nigeria’s healthcare infrastructure.

Dr. Francis Aminu, Director of Health and Nutrition at ADF, emphasized the foundation’s dedication to improving the lives of Nigerians, particularly in the health sector.

“What we do at ADF isn’t just charity, it’s a duty. We believe that every Nigerian life is valuable, and health is the foundation on which all other aspirations are built; no Nigerian should be left behind due to a lack of access to essential health resources,” he stated.

Health

Sufferer of Kidney Failure, Sewanu, Needs Your Help

Dialisys is 55k per session at Gbagada hospital but in some places it’s over 130k. So this is how I have been doing it since until later I was told at the hospital to go for kidney transplant but before I go for transplant, I will still be doing my dialisys twice a week.

Published

1 month ago

April 18, 2025

OCHEFA

Shared by Dr Love , on X (Twitter):

My name is Hosu moses sewanu, a native of Ipokia local government in ogun state, was born and raised in Lagos state .

My dad is late, I still have my mum and am the second out of the family of 3.

It all started late 2023, I woke one morning and I noticed that the left side of my head was seriously pounding so I took paracetamol just like the normal thing thinking it was just an ordinary headache but after taking the paracetamol few minute later the headache started again to the extent that it was difficult for me to turn my neck so I managed it like that for about 3 days but when the aching didn’t stop I had to call my mum to tell her what I was facing so she said to me that I should try and come over to her place, on getting to my mum’s place.

She decided that I have to go to Randle general hospital that I should go and complain there about my health.

Immediately I got to Randle, checking my blood pressure level, it was very high and I was referred to the emergency department for quick response, at the emergency, I was required to do some laboratory tests which I did.

So I was admitted immediately for about 4 days, later the doctor told me to go and redo the same test again at another laboratory center outside the hospital. When the results came out, it was reading that I am having chronic kidney failure.

When I was told about the situation, my entire body was very buttered that I almost run mad.

When my mum came. She was also told the same thing then I was referred to gbagada general hospital for proper treatment and to be seeing a neufrologist that is the specialist doctor for kidney cases.

So I started visiting gbagada hospital for check ups and clinic days. By that time my body have not started noticing it like that nor until late 2024

I started feeling very weak, I don’t sleep at night, I couldn’t eat like that, my entire body was down.

So I tried going back to the hospital at Gbagada, there I was admitted instantly and they started the treatment process, later on, I was told to start dialisys, that I should do five, so I started dialisysing at Gbagada hospital at first It was five. After doing the five, I was told to start another five again .

Making it 10 sessions ater doing the 10th session I was discharged home just to be attending the clinic alone, later I was told at the clinic that I should not stop the dialisys that this time, I have to be doing it twice a week.

So far now, I have done 23 sessions of dialisys and still counting. As it is now, I don’t work again, I can’t even do anything now, even to move around like before is really difficult because the whole thing have started manifesting I mean my body can’t carry me like before.

I am in very severe pain, the drugs prescribed for me by the doctors are very expensive and they are much all are compulsory for me to buy.

Hmm I pray that God should send me help from above, a miracle is what I am expecting.

This is the little I can say about my state of health now.

0119741433 GT bank account, Hosu Moses sewanu

1229255323 Zenith bank

Health

JUST IN: Ogun confirms Lassa fever outbreak as NYSC member dies

Published

2 months ago

March 26, 2025

Charles Flames

A 25-year-old member of the National Youth Service Corp (NYSC), has reportedly died of Lassa fever at a secondary health facility in ljebu North Local Government Area of Ogun State.

It wwas learnt that the female corp member who fell sick while in Ondo State, was brought to the health facility last Tuesday and later died same day.

This was contained in a statement signed by the Commissioner for Health, Tomi Coker, on Wednesday.

Coker also confirmed the outbreak of Lassa fever in the state.

The statement reads, “Ogun State has confirmed a case of Lassa Fever and as such declared Lassa fever outbreak.

“The index case is a 25-year-old female National Youth Corp member who fell sick while in Ondo State and was brought to on of our secondary health facility in ljebu North LGA on 18th March 2025 and later died same day.

“ Lassa fever is a viral Haemorrhagic disease that presents with High grade fever, Headache, General body weakness, Sore throat, Muscle pain, Cough, Nausea, Vomiting, Diarrhoea, Chest pain and Unexplained bleeding from the ears, eyes, nose, mouth and other body openings.

”Coker urged members of the community to report to the hospital if any of the listed symptoms is noticed.

“We implore members of the community to promptly report to the hospital if they notice any of these symptoms.

Any case of febrile illness that has not responded to 48 hours use of anti-malaria or antibiotics should raise an index of suspicion for Lassa fever!

“We implore all Health facilities in Ogun State, public and private, to step up Infection Prevention and Control measures and to encourage compliance by all health facility staff.“

Healthcare worker that suspects Lassa fever in a patient, are advised to call their local government disease surveillance and notification officer (LGA DSNO) whose numbers are placed in our health facilities or call State Disease surveillance and Notification Officer (0703-421-4893) or State Epidemiologist (0808-425-0881),” she added.

The commissioner, however reiterated the Governor Dapo Abiodun-led administration’s dedication to protecting the health of the citizens through continuous surveillance and prompt response to infectious diseases.

She added that the ministry in collaboration with the Rapid Response Team at ljebu North East is keeping the situation under control with enhanced surveillance and community engagement and mobilization for effective response.